Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BCR-ABL Positive Chronic Myelogenous Leukemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004918
What this trial is testing

Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Myeloid Leukemia in RemissionChronic Phase Chronic Myelogenous Leukemia+4 more
National Cancer Institute (NCI) 69
Not applicableStudy completedNCT05421091
What this trial is testing

Special Drug Use-results Surveillance of Scemblix Tablets

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 550
Testing effectiveness (Phase 2)Study completedNCT00955916
What this trial is testing

CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
H. Lee Moffitt Cancer Center and Research Institute 38
Testing effectiveness (Phase 2)Study completedNCT00719836
What this trial is testing

SB1518 for the Treatment of Advanced Myeloid Malignancies

Who this might be right for
Acute Myelogenous LeukemiaChronic Myelogenous LeukemiaChronic Myelomonocytic Leukemia+2 more
S*BIO 76
Not applicableStudy completedNCT01395628
What this trial is testing

Cell Samples From Patients With Leukemia

Who this might be right for
Leukemia
Children's Oncology Group 10
Testing effectiveness (Phase 2)Study completedNCT02269267
What this trial is testing

The Life After Stopping Tyrosine Kinase Inhibitors Study (The LAST Study)

Who this might be right for
Leukemia, Myeloid, Chronic
Medical College of Wisconsin 173
Not applicableStudy completedNCT00521430
What this trial is testing

Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+3 more
Asan Medical Center 30
Not applicableActive Not RecruitingNCT04645706
What this trial is testing

Innate T Cells and TKI Discontinuation

Who this might be right for
Chronic Myeloid Leukemia
Poitiers University Hospital 92
Testing effectiveness (Phase 2)Ended earlyNCT01050764
What this trial is testing

Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

Who this might be right for
Leukemia, AcuteChronic Myelogenous Leukemia (CML)Myelodysplastic Syndrome (MDS)+4 more
Everett Meyer 10
Early research (Phase 1)Study completedNCT00005593
What this trial is testing

Fludarabine, Carboplatin, and Topotecan in Treating Patients With Relapsed/Refractory Acute Leukemia or Advanced Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Case Comprehensive Cancer Center 31
Not applicableLooking for participantsNCT07549516
What this trial is testing

A Study on the Tolerability, Safety and Effectiveness of Asciminib in Patients With Philadelphia Chromosome-positive Chronic Myeloid Leukemia in the Chronic Phase in Germany

Who this might be right for
Leukemia, Chronic Myeloid
Novartis Pharmaceuticals 380
Large-scale testing (Phase 3)Study completedNCT02736721
What this trial is testing

Expanded Access Study With Peginterferon Alfa-2a (Pegasys) in Participants With Chronic Myelogenous Leukemia (CML)

Who this might be right for
Myelogenous Leukemia, Chronic
Hoffmann-La Roche 41
Testing effectiveness (Phase 2)Study completedNCT00005797
What this trial is testing

Bone Marrow Transplant in Treating Patients With Hematologic Cancers

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaMultiple Myeloma and Malignant Plasma Cell Neoplasms+2 more
H. Lee Moffitt Cancer Center and Research Institute 125
Testing effectiveness (Phase 2)Looking for participantsNCT05884333
What this trial is testing

Cord Blood Transplant in Adults With Blood Cancers

Who this might be right for
Acute Myelogenous Leukemia (AML)Acute Lymphoblastic Leukemia (ALL)Chronic Myelogenous Leukemia (CML)+3 more
Memorial Sloan Kettering Cancer Center 54
Early research (Phase 1)Looking for participantsNCT07651878
What this trial is testing

Phase I Trial of Vididencel in CML-CP Patients With MRD Under TKI Treatment

Who this might be right for
CML (Chronic Myelogenous Leukemia)
Mendus 24
Not applicableStudy completedNCT02842333
What this trial is testing

Study of Predictive Immunological Parameters of Molecular Complete Remission in Patients With Chronic Myelogenous Leukemia in Chronic Phase and Treated With Tyrosine Kinase Inhibitor

Who this might be right for
Chronic Leukemia
Centre Hospitalier Universitaire de Besancon 57
Not applicableStudy completedNCT02733445
What this trial is testing

Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib

Who this might be right for
Chronic Myeloid Leukemia (CML)
Bristol-Myers Squibb 2,650
Early research (Phase 1)Active Not RecruitingNCT05434312
What this trial is testing

TGRX-678 Chinese Phase I in Chronic Myelogenous Leukemia (CML) Patients

Who this might be right for
Chronic Myelogenous Leukemia
Shenzhen TargetRx Co., Ltd. 90
Testing effectiveness (Phase 2)Study completedNCT00003230
What this trial is testing

Paclitaxel in Treating Patients With Refractory or Recurrent Acute Leukemia or Chronic Myelogenous Leukemia

Who this might be right for
Leukemia
Swiss Cancer Institute 33
Testing effectiveness (Phase 2)Study completedNCT00101595
What this trial is testing

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Who this might be right for
Chronic Myeloid LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-positive
Bristol-Myers Squibb 96
Next Page